Advertisement
News
Advertisement

Advanced Life Sciences Featured as Special Stock Pick by KonLin Investment Letter

Thu, 08/05/2010 - 5:33am
Bio-Medicine.Org

CHICAGO, Aug. 5 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced that the Company has been featured as a special stock pick for August, 2010 by "The KonLin Letter," a 27 year old independent, financial newsletter (www.konlin.com). This is an unsolicited and unpaid evaluation of Advanced Life Sciences, performed by KonLin Research & Analysis.

(Logo:  http://photos.prnewswire.com/prnh/20080218/ALSLOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20080218/ALSLOGO)

Highlights from The KonLin Letter include:  

  • A recommendation "to accumulate positions for a 1st target of $0.25 then $0.50, since the CDC has warned that previously treatable diseases, such as pneumonia, are again becoming untreatable due to the alarming growth in antibiotic resistance."  "Ultimate target <

    '/>"/>

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading